0914 GMT - CVS Group's disposal of its crematorium division helps simplify the company's structure and sheds a business unit that provides a minor contribution to earnings, Davy Research analyst Colin Grant says. The analyst adds in a research note that the division can be considered non-core. "Overall, we view this disposal as opportunistic and attractive," Grant says. At a sale price of 42.4 million pounds, the disposal underscores the undervaluation of the rest of the company, the analyst says. The company expects to post a one-off 32.0 million pounds gain in its year-end account from the sale. CVS Group's shares trade 2.4% higher at 1,030 pence. (pierre.bertrand@wsj.com)
(END) Dow Jones Newswires
April 24, 2025 05:14 ET (09:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。